BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Nosology
,
Doxorubicin
,
rs2230926
,
SNCA
,
Coagulation
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Gonadotrophin-releasing hormone receptor family
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Endometrium
Synovial membrane
Joint synovium
Hypothalamus
Penis
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vitamin D deficiency
Disorder of pituitary gland
Lyme disease
Disorder of endocrine gonad
Zika virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
abarelix
butyraldehyde
Aroclors
benz(a)anthracene
pentanal
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGD5-AS1
MIR10B
POU1F1
MET
SOCS3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Induced neural progenitor cells with conditional overexpresison of MIR10A or MIR10B
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
OMIM - Hypogonadism disorder
Clear cell renal cell carcinoma cells - S100A6 overexpression or knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Gonadotrophin-releasing hormone receptor family
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prost…
Chromosome 18 Clinical Research Center
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Pros…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ